Published in J Am Acad Dermatol on November 01, 1984
Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest (1993) 1.16
Epidermolysis bullosa acquisita. Clin Dermatol (2011) 1.14
Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med (2007) 1.10
The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens. J Biol Chem (2012) 1.04
Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen. Autoimmunity (2011) 0.85
Epidermolysis bullosa acquisita--successful treatment with colchicine. Arch Dermatol Res (1994) 0.81
Salt split technique: a useful tool in the diagnosis of subepidermal bullous disorders. Indian J Dermatol (2010) 0.79
Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype. J Clin Immunol (2000) 0.77
Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells. Clin Exp Immunol (2006) 0.76
A Case of Bullous Skin Disease Presenting with Odynophagia: A Diagnostic Challenge. Case Rep Dermatol Med (2016) 0.75
Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters. J Invest Dermatol (2015) 0.75
Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol (1991) 2.79
Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol (1988) 2.00
Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97
Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol (1984) 1.85
Epidermolysis bullosa dystrophica-recessive: a possible role of anchoring fibrils in the pathogenesis. J Invest Dermatol (1975) 1.80
Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med (1984) 1.80
Herpes zoster in seven disparate dermatomes (zoster multiplex): report of a case and review of the literature. J Am Acad Dermatol (1999) 1.71
Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. Proc Natl Acad Sci U S A (1991) 1.66
Identification and partial characterization of pemphigoid antigen extracted from normal human skin. J Invest Dermatol (1984) 1.61
Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. JAMA (1992) 1.60
The epidermal-dermal junction. J Invest Dermatol (1975) 1.60
Nck/Dock: an adapter between cell surface receptors and the actin cytoskeleton. Oncogene (2001) 1.57
Interactions of basement membrane components. Biochim Biophys Acta (1983) 1.57
Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol (1981) 1.55
Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest (1988) 1.52
Congenital localized absence of the skin as a manifestation of epidermolysis bullosa. Arch Dermatol (1992) 1.51
Formation and origin of basal lamina and anchoring fibrils in adult human skin. J Cell Biol (1971) 1.48
Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers. J Am Acad Dermatol (1997) 1.41
Eczema herpeticum, primary and recurrent. Arch Dermatol (1966) 1.41
Hailey-Hailey disease is not allelic to Darier's disease. J Invest Dermatol (1994) 1.40
Autosomal dominantly inherited generalized basaloid follicular hamartoma syndrome: report of a new disease in a North Carolina family. J Am Acad Dermatol (2000) 1.39
Enhanced modulation of keratinocyte motility by transforming growth factor-alpha (TGF-alpha) relative to epidermal growth factor (EGF). J Invest Dermatol (1996) 1.39
Characterization of cellular elements in healed cultured keratinocyte autografts used to cover burn wounds. Arch Dermatol (1990) 1.39
Cutaneous plasmacytomas. A review and presentation of an unusual case. J Am Acad Dermatol (1979) 1.38
Leukokeratoderma estrovale digitorum inversa. J Am Acad Dermatol (1996) 1.38
Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin. J Biol Chem (1997) 1.37
Calcium-induced assembly of adherens junctions in keratinocytes. J Cell Biol (1987) 1.36
Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol (1999) 1.34
Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol (1998) 1.31
Pathogenesis of recurrent herpes simplex infections. J Invest Dermatol (1975) 1.28
Hypoxia increases human keratinocyte motility on connective tissue. J Clin Invest (1997) 1.27
Epidermal growth factor (EGF) promotes human keratinocyte locomotion on collagen by increasing the alpha 2 integrin subunit. Exp Cell Res (1993) 1.24
Nckbeta adapter regulates actin polymerization in NIH 3T3 fibroblasts in response to platelet-derived growth factor bb. Mol Cell Biol (2000) 1.24
An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J Invest Dermatol (1982) 1.23
Human keratinocyte locomotion: the effect of selected cytokines. J Invest Dermatol (1992) 1.21
Recessive dystrophic epidermolysis bullosa phenotype is preserved in xenografts using SCID mice: development of an experimental in vivo model. J Invest Dermatol (1992) 1.20
Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. A double-blind study. J Am Acad Dermatol (1986) 1.17
Differential proteolytic susceptibility of laminin alpha and beta subunits. Arch Biochem Biophys (1982) 1.16
Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest (1993) 1.16
Laminin-5 inhibits human keratinocyte migration. Exp Cell Res (1997) 1.15
Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med (1984) 1.14
A case of linear IgA disease presenting initially with IgG immune deposits. J Am Acad Dermatol (1986) 1.14
Sézary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood (1996) 1.13
Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies. Arch Dermatol (1995) 1.12
Epidermal-dermal interactions in adult human skin: role of dermis in epidermal maintenance. J Invest Dermatol (1968) 1.12
Spreading and enhanced motility of human keratinocytes on fibronectin. J Invest Dermatol (1985) 1.12
Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression. Mol Biol Cell (2000) 1.11
NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. J Invest Dermatol (1999) 1.10
Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest (1992) 1.09
The large non-collagenous domain (NC-1) of type VII collagen is amino-terminal and chimeric. Homology to cartilage matrix protein, the type III domains of fibronectin and the A domains of von Willebrand factor. Hum Mol Genet (1992) 1.09
In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline. J Am Acad Dermatol (1983) 1.09
Cutaneous wound healing: a model for cell-matrix interactions. J Am Acad Dermatol (1985) 1.09
Integrin receptors and RGD sequences in human keratinocyte migration: unique anti-migratory function of alpha 3 beta 1 epiligrin receptor. J Invest Dermatol (1992) 1.08
Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin. J Invest Dermatol (1980) 1.08
Aging and cross-linking of skin collagen. Biochem Biophys Res Commun (1988) 1.08
Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. J Clin Invest (1996) 1.07
Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2. Arch Biochem Biophys (1996) 1.07
HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI. Int J Cancer (1998) 1.06
Epidermolysis bullosa acquisita antigen, a major cutaneous basement membrane component, is synthesized by human dermal fibroblasts and other cutaneous tissues. J Invest Dermatol (1986) 1.05
Human nevocellular nevus cells are surrounded by basement membrane components. Immunohistologic studies of human nevus cells and melanocytes in vivo and in vitro. Lab Invest (1988) 1.04
Monoclonal antibodies to anchoring fibrils for the diagnosis of epidermolysis bullosa. J Invest Dermatol (1983) 1.04
Epidermolysis bullosa: gastrointestinal manifestations. Ann Intern Med (1974) 1.04
Mechanism of lesion production in pemphigus and pemphigoid. J Am Acad Dermatol (1982) 1.04
Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol (1990) 1.04
Induction of keratinocyte IL-8 expression and secretion by IgG autoantibodies as a novel mechanism of epidermal neutrophil recruitment in a pemphigus variant. Clin Exp Immunol (2000) 1.03
Vitronectin-driven human keratinocyte locomotion is mediated by the alpha v beta 5 integrin receptor. J Biol Chem (1994) 1.02
Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol (1993) 1.02
Cutaneous manifestations of disseminated cryptococcosis. Arch Dermatol (1976) 1.01
Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Dermatol Clin (1993) 1.00
Burn wounds resurfaced by cultured epidermal autografts show abnormal reconstitution of anchoring fibrils. JAMA (1988) 0.99
Preparation and characterization of a viable suspension of postembryonic human epidermal cells. J Invest Dermatol (1967) 0.99
The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis Bullosa acquisita autoantibodies. J Biol Chem (2001) 0.99
Lamellar ichthyosis: long-term graft studies on congenitally athymic nude mice. J Invest Dermatol (1976) 0.98
A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen. J Invest Dermatol (1985) 0.98
Structure and function of basement membrane. J Invest Dermatol (1982) 0.98
Epidermolysis bullosa acquisita: update and review. Clin Dermatol (2001) 0.98
Localization of the alpha 3 (V) chain of type V collagen in human skin. J Invest Dermatol (1987) 0.97
Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol (1997) 0.97